Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Dyadic International Inc is a biotechnology company. It is engaged in the development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries. The company has developed a method for producing commercial quantities of enzymes and other proteins, which it used to develop and produce some of its own industrial enzymes, as well as licensing this technology to third parties such as Abengoa Bioenergy, BASF, Codexis, and others. This technology is based on the Myceliopthora thermophila fungus, which the company named C1. The group conducts operations in the Netherlands through its foreign subsidiary and generates a large portion of its revenues from customers that are located outside of the United States.
Jupiter, FL, 33477